| Income Statement |
| Total Revenue | 42.95M |
|
| Revenues (USD) | 42.95M |
| Cost of Revenue | 20.23M |
| Gross Profit | 22.72M |
| Operating Expenses | 27.61M |
| Research and Development Expense | 1.50M |
| Selling, General and Administrative Expense | 16.22M |
| Operating Income | -4.90M |
| Interest Expense | 5.17M |
| Net Income | -21.70M |
| Net Income Common Stock | -21.70M |
| Net Income Common Stock (USD) | -21.70M |
| Consolidated Income | -21.35M |
| Net Income to Non-Controlling Interests | 346.00K |
| Earnings per Basic Share | -0.09 |
| Earnings per Basic Share (USD) | -0.09 |
| Earnings per Diluted Share | -0.09 |
| Earning Before Interest & Taxes (EBIT) | -16.53M |
| Earning Before Interest & Taxes (USD) | -16.53M |
| Weighted Average Shares | 236.84M |
| Weighted Average Shares Diluted | 236.84M |
| Balance Sheet |
| Cash and Equivalents | 78.90M |
| Cash and Equivalents (USD) | 78.90M |
| Trade and Non-Trade Receivables | 9.74M |
| Current Assets | 115.87M |
| Property, Plant & Equipment Net | 361.50M |
| Total Assets | 653.50M |
| Debt Current | 951.00K |
| Total Debt | 170.23M |
| Current Liabilities | 26.89M |
| Debt Non-Current | 169.28M |
| Total Liabilities | 198.80M |
| Accumulated Retained Earnings (Deficit) | -855.62M |
| Shareholders Equity | 447.75M |
| Shareholders Equity (USD) | 447.75M |
| Assets Non-Current | 537.64M |
| Total Debt (USD) | 170.23M |
| Goodwill and Intangible Assets | 103.64M |
| Inventory | 21.59M |
| Liabilities Non-Current | 171.91M |
| Trade and Non-Trade Payables | 25.94M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.04M |
| Net Cash Flow from Financing | -7.77M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -38.04M |
| Capital Expenditure | -8.87M |
| Issuance (Purchase) of Equity Shares | -299.00K |
| Issuance (Repayment) of Debt Securities | -7.47M |
| Net Cash Flow from Investing | -9.12M |
| Net Cash Flow from Operations | -21.14M |
| Share Based Compensation | 2.10M |